Science Explorer Back to mapMap
Discussion
Researcher · Noxxon Pharma (Germany) · Germany

Axel Vater

Axel Vater publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Complement system in diseases, Advanced biosensing and bioanalysis techniques and Chemokine receptors and signaling.

ORCID 0000-0003-4166-982X OpenAlex
World rank
#852,827
of 7,710,434 ranked researchers
Rank in Germany
#42,024
of 364,343
Works
68
Citations
2.8k
Citations per work
41.7
h-index
25
i10-index 35Top 21% in Immunology
Axel Vater

What does Axel Vater research?

Axel Vater's work is mostly in Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (21%), Medicine (16%).

Life Sciences: 28 works · 41.6% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 20.8% of their workMolecular Biology: 14 works · 20.8% of their workImmunology and Microbiology: 14 works · 20.8% of their workImmunology: 14 works · 20.8% of their workEverything else: 25 works · 37.0% of their workHealth Sciences: 11 works · 16.4% of their workMedicine: 11 works · 16.4% of their workOncology: 6 works · 8.2% of their workOphthalmology: 3 works · 4.4% of their workCardiology and Cardiovascular Medicine: 3 works · 3.8% of their workPhysical Sciences: 3 works · 5.0% of their workEngineering: 3 works · 5.0% of their workBiomedical Engineering: 3 works · 5.0% of their workTHEIR WORKAxel Vater68works
Life Sciences42%Physical Sciences5%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1420.8%
    2. Immunology and Microbiology1420.8%
  2. Everything else2537.0%
    1. Medicine1116.4%
    1. Engineering35.0%
  1. 1Immunology21% of their works
  2. 2Molecular Biology21% of their works
  3. 3Oncology8% of their works
  4. 4Biomedical Engineering5% of their works
  5. 5Ophthalmology4% of their works
  6. 6Cardiology and Cardiovascular Medicine4% of their works

Research topics

Which keywords describe Axel Vater's research?

The keywords of their largest research topics: Innate Immunity, Complement, Immune, DNA nanotechnology, Self-Assembly, Gene Therapy, Cancer Metastasis and Chemokine Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Innate Immunity162 topics
  2. Complement111 topic
  3. Immune111 topic
  4. DNA nanotechnology101 topic
  5. Self-Assembly101 topic
  6. Gene Therapy92 topics
  7. Cancer Metastasis71 topic
  8. Chemokine Receptors71 topic
  9. RNA Interference61 topic
  10. siRNA Delivery61 topic
  11. Dendritic Cells51 topic
  12. Immunity51 topic
  13. NK Cell Recognition51 topic
  14. Natural Killer Cells51 topic
  15. Immune Checkpoint Blockade41 topic
  16. PD-1 and PD-L141 topic
  17. Retinal Stem Cells31 topic
  18. Retinitis Pigmentosa31 topic

Where does Axel Vater work?

Axel Vater's main affiliation in the publication record is Noxxon Pharma (Germany), Germany.

How many publications and citations does Axel Vater have?

OpenAlex counts 68 works and 2,833 citations for Axel Vater, an h-index of 25, ranking #852,827 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Axel Vater. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.